Paranasal sinus carcinoma is rare, with an estimated annual incidence of less than 1 per 100,000 population. Primary frontal sinus involvement is extremely rare, accounting for only in 0.3% of all paranasal sinus malignancies. A frontal sinus cancer may be mistaken for a mucocele, pyocele, or osteomyelitis. We report the case of a 48-year-old woman with a carcinoma that originated in the frontal sinus. Computed tomography and magnetic resonance imaging demonstrated bony destruction with intracranial extension but no involvement of the bulbus. Th e patient underwent a frontal craniotomy, tumor excision, and postoperative radiotherapy. One year later, she remained symptom-free.
Introduction
Malignancies of the nose and paranasal sinuses are uncommon, accounting for only 3% of all head and neck cancers; the estimated annual incidence is less than 1 per 100,000 population. 1 Primary carcinoma of the frontal sinus is exceedingly rare, as it represents only about 0.3% of all paranasal sinus malignancies. 1 In the frontal sinus, squamous cell carcinoma is far more common than adenocarcinoma, by a ratio of 20:1. Th is condition may be mistaken for a mucocele, pyocele, or osteomyelitis. 2 We report a new case of primary frontal sinus squamous cell carcinoma.
Case report
A 48-year-old woman presented to our department with a 2-month history of swelling of the forehead, a narrow palpebral aperture, and occasional dull frontal and orbital pain. She reported no history of double vision, decreased vision, headache, blood-stained nasal discharge, epistaxis, or nasal obstruction, and she had not been exposed to nickel, asbestos, or wood dust. She had no signifi cant surgical history.
On examination, a diff use, ill-defi ned, fi rm, smooth, nontender, nonpulsatile, 5 × 4-cm swelling was present on the forehead, more so on the left side than the right (fi gure 1). Th e swelling involved the supraorbital margin and the area medial to the medial canthus. Despite the narrowed palpebral aperture, the patient's visual acuity and eye movements were normal, and there was no ptosis or exophthalmos. Findings on examination of the nasal cavity were within normal limits.
Computed tomography (CT) revealed an uneven, contrast-enhancing soft -tissue mass involving the left frontal sinus. Th e mass had destroyed the intersinus septum and extended to the right frontal sinus (fi gure Figure 1 . At presentation, the patient exhibits a diff use, ill-defi ned, 5 × 4-cm swelling on the forehead, more so on the left side than the right. the frontal sinus and extend to contiguous structures such as the anterior ethmoid sinuses, the site of tumor origin cannot be defi nitively determined. However, radiologic and surgical assessments of the tumor may yield some clues to the primary site of origin in the frontal sinus. 4, 5 Patients with a frontal sinus tumor usually present with nonspecifi c signs and symptoms such as swelling, pain, and vision disturbances. Rhinorrhea, purulent nasal discharge, mental apathy, and convulsions occasionally occur. Th ese signs and symptoms may mimic those of infl ammatory lesions, and therefore they are oft en not diagnosed until they have reached an advanced stage. 1, 4, 5 In rare cases, cutaneous manifestations such as itching, pain, and numbness over a skin nodule may occur. In 1967, Osborn and Wallace reported a case of frontal sinus carcinoma that arose 5 years following the removal of a 2, A). Erosion of the anterior and posterior walls of the frontal sinus was noted, along with involvement of the subcutaneous tissues and extradural intracranial cavity. Th e upper portion of the medial wall of the orbit was also eroded (fi gure 2, B). Th e bony erosion was suspicious for malignant disease. Magnetic resonance imaging (MRI) also demonstrated a contrast-enhancing softtissue tumor involving the frontal sinuses bilaterally and extending to the anterior cranial fossa extradurally, without involvement of the bulbus (fi gure 3).
During a multidisciplinary discussion, it was decided that a frontal craniotomy would be performed with the goal of removing the tumor while preserving the left bulbus if possible. A crossbow incision was made (fi gure 4), and the tumor was removed in toto (fi gure 5), along with the anterior and posterior walls of the frontal sinus. Th en a galeal-pericranial fl ap was placed. Th e bony orbital roof was drilled out with a diamond bur. No direct involvement of the bulbus was noted. Histopathology of the tumor specimen revealed it to be a poorly diff erentiated squamous cell carcinoma.
Th e patient's postoperative period was uneventful. Four weeks following surgery, she received 64 Gy of external-beam radiotherapy over 6 weeks, which had an adverse eff ect on her vision. At follow-up 12 months postoperatively, the forehead swelling was absent and the palpebral narrowing had resolved somewhat (fi gure 6). One year aft er the completion of radiotherapy, the patient was symptom-free, and she exhibited no evidence of recurrence.
Discussion
Prawssud published the fi rst reported case of a histologically proven squamous cell carcinoma of the frontal sinus in 1907. 3 In the case of large tumors that involve cholesteatoma at the same site; they suggested that the epidermoid cholesteatoma might have been the source of origin of the carcinoma. 5 In 1975, Robinson reported a case of frontal sinus malignancy that presented with features of a frontal mucocele. 6 In a case described by Reddy et al in 1991, a frontal sinus carcinoma mimicked acute frontal sinusitis. 7 CT and MRI are used in the evaluation of tumor extent and involvement of orbital and intracranial structures. In our case, CT and MRI ruled out deep orbital extension, although we acknowledge that preservation of the bulbus was a debatable decision.
Th e complex anatomy of the area and an advanced tumor stage at presentation make it diffi cult to perform an excision with adequate margins; as a result, the prognosis is oft en poor. 1, 5 Regardless, the assessment of prognosis is generally diffi cult because of the rarity of these tumors and the diversity of the histologic types and treatment. To the best of our knowledge, no prospective controlled studies of primary frontal sinus tumors have been published in the literature.
In 1971, Brownson and Ogura advocated a combination of radical surgery and postoperative radiotherapy, but we still do not have enough experience to determine if this method improves survival. 8 Th e same year, Harrison recommended palliative excision alone for advanced sinonasal tumors because resection with adequate margins is usually not possible and because radical excision would only compound the patient's suff ering. 9 We performed a bifrontal craniotomy, and the tumor was excised along with the anterior and posterior walls of the frontal sinuses. Th is was followed later by radiotherapy for 6 weeks. In 1995, Raveh et al described the subcranial approach, which combines a bifrontal craniotomy with naso-orbital osteotomies for broad exposure of the anterior cranial fossa, nasal cavity, and paranasal sinuses. 10 Th is approach involves no frontal lobe retraction, it results in a shorter distance to the tumor, and it allows for a possible unilateral preservation of olfaction. Combined with adjuvant radiotherapy, the anterior craniofacial approach improved 5-year survival. However, the primary reason for a poor outcome is local failure. 1, 5 Complications of this surgery include cerebrospinal fl uid leakage, abscess formation, and pneumocephalus. In our case, no complications occurred.
In 2007, Guntinas-Lichius et al proposed that radical surgery is the treatment of choice for patients with stage I or II malignant sinonasal tumors. 11 Th ey reported that the prognosis for patients with stage III or IV tumors was poor, although multimodality treatment may improve outcomes. To date, no controlled trials have established the eff ectiveness of radiotherapy and chemotherapy in improving survival in patients with a frontal sinus malignancy, but these treatments are helpful for local control. Th e positive response rate with chemotherapy has been approximately 82%. 1 A cisplatin-based regimen augmented with 5-fl uorouracil and bleomycin appears to be eff ective. Some authors have advocated radioand chemotherapy preoperatively. 1, 11 Radiotherapy alone-even 3-dimensional conformal radiation-has been ineff ective in patients with advanced sinonasal malignancies. 12 Associated morbidities include dry eyes, optic nerve damage, and radionecrosis. In 2004, Rischin et al reported a 2-year overall survival of 64% in patients with T4 sinonasal undiff erentiated carcinoma following simultaneous hyperfractionated radiotherapy and cisplatin-based chemotherapy. 13 In view of the poorly diff erentiated nature of the tumor in our patient, we opted for postoperative radiotherapy. Several factors lead us to feel optimistic about improving survival rates in patients with advanced frontal sinus malignancies; among them are (1) the ability of CT and MRI to evaluate orbital and intracranial extension of frontal sinus and anterior skull base tumors and (2) the evolution of subcranial surgery, craniofacial resection, and modern reconstructive techniques involving microvascular anastomoses combined with multimodality treatment regimens.
